logo

The goal of my research program is to work with knowledge users to inform national and international decisions about optimal infectious disease control and prevention strategies in the context of limited resources, and to provide better modeling tools for policy decisions. My team and I develop state-of-the-art transmission-dynamic models, analyze large population-level datasets, and use epidemiology and health economics to estimate the effectiveness and cost-effectiveness of infectious disease control and prevention strategies at the population-level and within vulnerable or at-risk groups.

News

March 2025
EUROGIN2025 CONGRESS

Marc Brisson and Mélanie Drolet were invited speakers at the EUROGIN2025 International Multidiscinplary HPV Congress, held in Porto from March 16-19, 2025.

Presentations:
Marc presented:

  • Modelling cervical cancer inequalities worldwide with and without enhanced HPV vaccination and screening efforts
  • Population-level impact of switching to one-dose HPV vaccination in high-income countries
  • Mélanie presented:

  • HPV vaccine effectiveness by number of doses as measured in real-world observational studies: an updated and critical review
  • Session chairs:
    Marc and Mélanie also chaired two sessions each:

  • Co-chaired: “Global inequalities in cervical cancer prevention: Are we currently on the oath to cervical cancer elimination?
  • Marc chaired: “Single dose HPV vaccination: updates across research domains
  • Mélanie chaired “Economics and modeling
  • March 2025
    TIER 1 CANADA RESEARCH CHAIR

    Marc Brisson has been awarded the Tier 1 Canada Research Chair in Mathematical Modeling and Health Economics of Infectious Diseases. It is a significant acknowledgement of the impact and relevance of his work. The chair’s research program goal is to work with knowledge users to inform national and international decisions about optimal infectious disease control and prevention strategies, in the context of limited resources.

    January 2025
    A DOCTORAL STUDENT FROM OUR GROUP HONORED

    Congratulations to Élodie Bénard, who successfully defended her doctoral thesis on January 15 and has been named to the Honour List of the Faculty of Graduate and Postdoctoral Studies at Université Laval! [ Honour List ]

    November 2024
    PUBLICATION IN ANNALS OF INTERNAL MEDICINE

    ‘Cost-effectiveness of extending human papillomavirus vaccination to population subgroups older than 26 years who are at higher risk for human papillomavirus infection in the United States’

    November 2024
    PUBLICATIONS IN THE JNCI MONOGRAPHS

    Our team contributed two articles to the October-November 2024 issue of the JNCI Monograph, focusing on the State of the Science of Single-Dose Prophylactic HPV Vaccination